Unrivaled convenience —
break down the clot with 2-mg Cathflo

Within reach—without delay

Easy storage and preparation right at the point of care
Minimizes treatment delays and disruptions to patient care
The only lytic marketed and available in a single-use, 2-mg vial
No age restriction necessary

Reference:

AlphaDetail. Hospital Thrombolytic Survey. January 2006–December 2006. San Mateo, Calif.

Indication: For restoration of function to central venous access devices (CVADs) as assessed by the ability to withdraw blood.

Safety Information: Cathflo Activase should not be administered to patients with known hypersensitivity to Alteplase or any component of the formulation. In the clinical trials, the most serious adverse events reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis. Cathflo Activase should be used with caution in the presence of known or suspected infections in the catheter.

Please see full Prescribing Information.

Site Map

Terms and Conditions

Disclaimer

Unrivaled convenience —break down the clot with 2-mg Cathflo

Unrivaled convenience —
break down the clot with 2-mg Cathflo